Development of circulating CD4⁺ T‐cell memory.

Autor: Soon, Megan SF, Engel, Jessica A, Lee, Hyun J, Haque, Ashraful

Publikováno v: Immunology & Cell Biology; Aug2019, Vol. 97 Issue 7, p617-624, 8p

STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria.

Autor: Wang Y; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Griffith University, School of Environment and Science, Nathan, Australia., De Labastida Rivera F; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Edwards CL; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia., Frame TC; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia., Engel JA; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Bukali L; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia., Na J; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; University of Queensland, School of Medicine, Brisbane, Australia., Ng SS; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany., Corvino D; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Institute of Experimental Oncology, University Hospital Bonn, Bonn, Germany., Montes de Oca M; York Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom., Bunn PT; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Soon MS; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Andrew D; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Loughland JR; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Zhang J; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Amante FH; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Barber BE; QIMR Berghofer Medical Research Institute, Brisbane, Australia., McCarthy JS; Victorian Infectious Diseases Services, Doherty Institute, University of Melbourne, Melbourne, Australia., Lopez JA; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Griffith University, School of Environment and Science, Nathan, Australia., Boyle MJ; QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Life Sciences Division, Burnet Institute, Melbourne, Australia., Engwerda CR; QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2023 Oct 02; Vol. 133 (19). Date of Electronic Publication: 2023 Oct 02.

Single-cell transcriptomics of alloreactive CD4+ T cells over time reveals divergent fates during gut graft-versus-host disease.

Autor: Engel JA; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Lee HJ; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Williams CG; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Kuns R; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Olver S; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Lansink LI; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Soon MS; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia., Andersen SB; Institute for Molecular Bioscience, University of Queensland, St. Lucia, Queensland, Australia., Powell JE; Garvan-Weizmann Centre for Cellular Genomics, Sydney, New South Wales, Australia.; UNSW Cellular Genomics Futures Institute, University of New South Wales, Sydney, New South Wales, Australia., Svensson V; Flagship Labs 60 Inc., Cambridge, Massachusetts, USA., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom., Hill GR; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Medical Oncology, University of Washington, Seattle, Washington, USA., Varelias A; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland, St. Lucia, Queensland, Australia., Koyama M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Haque A; QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia.; Department of Microbiology and Immunology, University of Melbourne, located at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Publikováno v: JCI insight [JCI Insight] 2020 Jul 09; Vol. 5 (13). Date of Electronic Publication: 2020 Jul 09.

B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

Autor: McKee SJ; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Tuong ZK; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Kobayashi T; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Doff BL; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Soon MS; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Nissen M; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Lam PY; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Keane C; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia., Vari F; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Moi D; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Mazzieri R; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Leggatt G; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia., Gandhi MK; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia., Mattarollo SR; The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Queensland, Australia.

Publikováno v: Oncoimmunology [Oncoimmunology] 2017 Dec 18; Vol. 7 (2), pp. e1393599. Date of Electronic Publication: 2017 Dec 18 (Print Publication: 2018).